Skip to content Skip to footer

Wide Spectrum Antibiotics: Broad Coverage for Critical Care

Effective, Hospital-Focused Anti-Infective Solutions for Rapid, Targeted Treatment.

 

WIDE SPECTRUM ANTIBIOTICS featuring advanced injectable drugs like Vancomycin (VANCO), Meropenem (BORINEM), Amikacin (AMIKACIN), and Ceftazidime (KILZACT) for hospital use.

Kilitch’s Wide Spectrum Antibiotics Injectable Range is designed to support the treatment of moderate to severe bacterial and fungal infections. With a broad range covering Gram-positive, Gram-negative, anaerobic, and fungal pathogens, this portfolio provides the flexibility to initiate empiric therapy and transition to targeted treatment based on clinical response and culture sensitivity. It supports infection management across ICUs, surgical wards, and tertiary care centres.

Product Range

  • Azithromycin Powder for Injection 500mg
  • Vancomycin for Injection 500mg/1000mg
  • Amikacin Sulphate Injection 500mg/2ml, 250mg/2ml
  • Gentamicin Injection 80mg/2ml, 20mg/ml
  • Piperacillin + Tazobactam Injection 2.25gm/4.5gm
  • Amoxicillin + Clavulanate for Injection 600mg/1.2gm
  • Meropenem for Injection 500mg/1000mg
  • Doripenem for Injection 500mg
  • Caspofungin for Injection 50mg/70mg

How it Works

Parenteral Delivery

Direct intravenous administration ensures rapid, predictable systemic exposure, achieving therapeutic levels quickly in critically ill patients.

Multi-Class Coverage

Combines β-lactams, aminoglycosides, glycopeptides, macrolides, carbapenems, and echinocandins, providing broad coverage for diverse pathogens.

Stewardship-Aligned

Supports rational antibiotic selection, escalation, and de-escalation, based on clinical response and microbiology data, ensuring effective and responsible use.

What it Fixes

Delays in Therapy Initiation

Ready-to-use injectable formulations designed for rapid preparation and prompt initiation of therapy.

Limited Coverage from Single-Molecule Portfolios

Offers broad-spectrum coverage across multiple antibiotic classes, addressing a wide range of pathogens.

Managing Resistant Infections

Provides treatment options for multidrug-resistant organisms, based on culture sensitivity.

Need for Rapid Escalation

Facilitates quick escalation in critically ill patients, with step-up therapy options.

Fragmented Antibiotic Sourcing

Streamlines procurement with a unified injectable range.

Who is it for?

Public & Private Hospitals

Effective for general wards, ICUs, and surgical units.

ICUs & Critical Care Units

For managing severe infections in critically ill and immunocompromised patients.

Oncology & Immunocompromised Care

Essential for patients with weakened immune systems requiring intensive anti-infective therapy.

Institutional Procurement & Tenders

Simplifies procurement for hospitals and government-funded programs, with consistent branding and quality.